Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Lactate programs PBX1 lactylation and mesangial proliferation in lupus nephritis
Enzhuo Liu, … , Zhenke Wen, Zhichun Liu
Enzhuo Liu, … , Zhenke Wen, Zhichun Liu
Published April 29, 2025
Citation Information: JCI Insight. 2025;10(11):e190838. https://doi.org/10.1172/jci.insight.190838.
View: Text | PDF
Research Article Metabolism

Lactate programs PBX1 lactylation and mesangial proliferation in lupus nephritis

  • Text
  • PDF
Abstract

Lupus nephritis (LN) constitutes the most common organ-threatening manifestation of systemic lupus erythematosus (SLE), with the pathological proliferation of mesangial cells (MCs) recognized as a critical factor in its pathogenesis and progression. Self-DNA-containing immune complex (DNA-IC) represents a prime pathogenic factor in SLE, yet its pathological effect on MCs remains unclear. In the present study, we elucidated the mechanism underlying the excessive proliferation of MCs following the recognition of DNA-IC in patients with LN. Here, we pinpointed that the excessive proliferation of MCs was attributed to an anomalous transition from the G1 to the S phase of the cell cycle in patients with LN. Mechanically, the dysfunction of P27 protein resulted in the aberrant G1-S phase transition, and the phenomenon was closely related to the ubiquitin-mediated degradation of its key transcription factor, PBX1. This degradation was regulated by lactylation of PBX1 in the site of Lys40 residue. The elevated lactylation level of PBX1 protein was caused by the upregulation of glycolysis levels induced by DNA-IC. Accordingly, targeting lactate production in MCs from patients with LN effectively alleviated their renal inflammation and fibrosis progression. Elevated lactate resulted in PBX1 lactylation, leading to excessive proliferation of MCs and, thus, serving as a promising therapeutic target for LN.

Authors

Enzhuo Liu, Chenghua Weng, Chenchu Yan, Xingchen Zhu, Xinyue Li, Mengdi Liu, Zhenke Wen, Zhichun Liu

×

Figure 2

Deficiency of PBX1 drives MC proliferation.

Options: View larger image (or click on image) Download as PowerPoint
Deficiency of PBX1 drives MC proliferation.
(A) Immunoblotting of P27 pr...
(A) Immunoblotting of P27 proteins in LN and HC MCs. β-Actin from same gel is shown under the corresponding blots as loading control (n = 6). (B) The proliferation of LN MCs was rescued upon P27 overexpression (OE), as reflected by CCK-8 assay (n = 10). (C) RT-qPCR detected the expression of CDKN1B mRNA of LN MCs (n = 8). (D) Database screening to identify the upstream transcription factors of P27. RT-qPCR analysis of the upstream transcription factors of P27 in HC MCs (n = 9 for each group). (E) The occupancy of PBX1 on the CDKN1B promoter was determined by CHIP assay (n = 6). (F) Immunoblot analysis of PBX1 in LN and HC MCs. β-Actin from same gel is shown under the corresponding blots as loading control (n = 5). (G) RT-qPCR detected the expression of PBX1 mRNA in HC and LN MCs (n = 8). (H) The PBX1 protein level was tested by immunoblot analysis in the presence or absence of the proteasome inhibitor MG132 (2 μM) or lysosome inhibitor bafilomycin A1 (0.1 μM) for 4 hours in LN MCs. The same samples were run on a separate gel for detecting β-actin (n = 5). Lines with whiskers show the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 with ANOVA plus Turkey’s method (D and H) and paired t test (A–C and E–G).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts